Clinical Trial: 09.0287
A randomized Phase III study of Conventional Whole Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) for Women with stage 0, I, or II Breast Cancer (Study # RTOG-0413 / NSABP B-39)
Protocol Number: RTOG-0413 / NSABP B-39
IRB Number: 09.0287
Principal Investigator: William J. Spanos, M.D., F.A.C.R.
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy in different ways may kill any tumor cells that remain after surgery. It is not yet known whether whole breast radiation therapy is more effective than partial breast radiation therapy in treating breast cancer.
PURPOSE: This randomized phase III trial is studying whole breast radiation therapy to see how well it works compared to partial breast radiation therapy in treating women who have undergone surgery for ductal carcinoma in situ or stage I or stage II breast cancer.
Study Location: James Graham Brown Cancer Center
Start Date: 08/11/2009
Study Status: Active
Phase: Phase III
BCC Disease: Breast
BCC Treatment: Breast Cancer
Enrollment and Eligibility
Enrollment Status: Active
Requirements: For detailed eligibility requirements, see ClinicalTrials.gov for Study ID RTOG-0413.
Contact Person: Kaleigh Farrell, CTC
Phone: (502) 562-3429
Fax: (502) 562-3462